To date (including this round), the company has raised $20 million. Its flagship product, a cultivated chicken breast, passed to the finals of the XPRIZE Feed the Next Billion (FTNB) competition last month. In September 2021, the biotech revealed dishes made with cultivated pork grown with cells from China’s native black pig. And in April 2022, CellX partnered with Bluu Seafood to “make cellular agriculture a reality” and advance regulatory approval in Germany and China.
Comments are closed.